CDC Panel Reverses Hepatitis B Vaccine Recommendation for Newborns

The CDC's advisory panel has voted 8-3 to discontinue the long-standing recommendation for all newborns to receive the hepatitis B vaccine. This decision marks a significant shift in public health policy, reflecting ongoing debates about vaccine safety and necessity, and overturns decades of guidance aimed at preventing infections and liver cancer in infants.